INX-SM-6

• Description :

  INX-SM-6 can be used for targeted delivery of anti-inflammatory agent. INX-SM-6 inhibits LPS-induced IL-1β production in human PBMCS[1].

• UNSPSC :

  12352203

• Target :

  ADC Payload

• Type :

  ADC Related

• Related Pathways :

  Antibody-drug Conjugate/ADC Related

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/inx-sm-6.html

• Purity :

  98.85

• Solubility :

  DMSO : ≥ 50 mg/mL

• Smiles :

  O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@H]5O)(O[C@@](C(S6)=CN=C6CC7=CC(N)=CC=C7)([H])O1)[C@]2(C5)C)CO

• Molecular Formula :

  C32H36N2O6S

• Molecular Weight :

  576.70

• References & Citations :

  [1]Jay ROTHSTEIN, et al. Anti-human vista antibodies and use thereof. WO2021216913A1

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  ADC Related

• Clinical Information :

  No Development Reported

• CAS Number :

  [2734878-16-9]